BSE: GLAND - Gland Pharma Limited
Yield per half year: 0%
Sector: Healthcare
Reporting Gland Pharma Limited
Share
IFRS
Annual
Quarterly
2020 | 2021 | 2024 | LTM | 5 year average | CAGR 5 | |
---|---|---|---|---|---|---|
EPS | 26.94 | |||||
Цена акции ао | 2225.81 | 2271.69 | 2449.4 | 2449.4 |
Efficiency
IFRS
Annual
2023 | 2024 | 2025 | LTM | Industry average | 5 year average | CAGR 5 | |
---|---|---|---|---|---|---|---|
ROS, % | 0 | 0 | 0 | 0 | -86.65 | ||
Operation Margin, % | 0 | 0 | 0 | 0 | -90.90 |
Coefficients
IFRS
Annual
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription